Clarus Therapeutics Holdings, Inc. (CRXTQ)

USD 0.0

(0.0%)

Eps Summary of Clarus Therapeutics Holdings, Inc.

  • Clarus Therapeutics Holdings, Inc.'s latest annual eps in 2021 was -8.04 USD , down -1476.47% from previous year.
  • Clarus Therapeutics Holdings, Inc.'s latest quarterly eps in 2022 Q2 was -0.24 USD , up 59.32% from previous quarter.
  • Clarus Therapeutics Holdings, Inc. reported an annual eps of -0.51 USD in 2020, down 0.0% from previous year.
  • Clarus Therapeutics Holdings, Inc. reported a quarterly eps of -0.59 USD for 2022 Q1, down 0.0% from previous quarter.
  • Clarus Therapeutics Holdings, Inc. reported a quarterly eps of N/A for 2021 FY, down -1476.47% from previous quarter.

Annual Eps Chart of Clarus Therapeutics Holdings, Inc. (2021 - 2020)

Created with Highcharts 11.1.0YearsEPS20202020.12020.22020.32020.42020.52020.62020.72020.82020.92021-10 USD-8 USD-6 USD-4 USD-2 USD0 USD

Historical Annual Eps of Clarus Therapeutics Holdings, Inc. (2021 - 2020)

Year Eps Eps Growth
2021 -8.04 USD -1476.47%
2020 -0.51 USD 0.0%

Peer Eps Comparison of Clarus Therapeutics Holdings, Inc.

Name Eps Eps Difference
AstraZeneca PLC 3.84 USD 309.375%
Bristol-Myers Squibb Company PFD CONV 2 3.88 USD 307.216%
CSPC Pharmaceutical Group Limited 0.07 USD 11585.714%
Novartis AG 7.63 USD 205.374%
PT Kalbe Farma Tbk. 0.00 USD 206253.846%